137.9 million. 3. Advances received from customers increased Baht 15.8 million. 4. Accrued income tax payable decreased Baht 22.8 million. 5. Long-term loans from financial institutions increased Baht

that unable to sell at market price and UWC’s subsidiaries have recognition the cost of closing project with residual income from delivery. (3) Expenses Quarter 1-2019 company and its subsidiaries has

) (32.8) Net profit 868 6.2 1,387 10.6 1,083 8.4 (37.4) (19.9) EPS (Baht) 0.70 1.11 0.87 Sales revenues and Service Income of this quarter amounting to Baht 13,915 million, went up 6.0% compared with the

and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for

% as compared to the same period of last year. The increase of net profit was mainly in respond to the product mix and other income during the period as compared. In additional, the impacts derived from

29.1 Finance costs 250.93 403.07 (152.14) (37.7) Income tax expense 215.17 164.03 51.14 31.2 Total expenses 2,211.89 2,102.74 109.15 5.2 2,175.99 2,309.70 (133.71) (5.8) Non-controlling Interests - (3.04

51% 405 599 48% Cost of sales (68) (111) 63% (132) (210) 59% Gross Profit 138 201 46% 273 389 42% Other Income 3 3 0% 5 5 0% Selling and distribution expenses (68) (85) 25% (134) (160) 19

follow: Income statements Second Quarterly Operational Performance The Company reported Revenues from Hospital Operations of Baht 213.42 million, a 50.09% increase year-over-year from Baht 142.19 million

Baht 37.3 million. 4. Accrued income tax payable decreased Baht 1.7 million. 5. Long-term loans from financial institutions increased Baht 1,797.0 million. 6. Employee benefit obligations increased Baht

manufacture and 3rd party’s products for distribution prove their successfulness in generating incremental sales and gross profits to the Group, creating stable income sources with growth potential and